<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Transl Androl Urol</journal-id><journal-id journal-id-type="iso-abbrev">Transl Androl Urol</journal-id><journal-id journal-id-type="publisher-id">TAU</journal-id><journal-title-group><journal-title>Translational Andrology and Urology</journal-title></journal-title-group><issn pub-type="epub">2223-4691</issn><publisher><publisher-name>AME Publishing Company</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4842605</article-id><article-id pub-id-type="publisher-id">tau-05-S1-AB207</article-id><article-id pub-id-type="doi">10.21037/tau.2016.s207</article-id><article-categories><subj-group subj-group-type="heading"><subject>Printed Abstracts</subject></subj-group></article-categories><title-group><article-title>AB207. Combined detrusor and external urethral sphincter botulinum toxin A injections is a safe and effective treatment for decreasing leak point pressure in patients with incontinence secondary to spinal cord injury</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Hui</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Keji</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Chonghe</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>MP</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>JB</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>QL</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>QQ</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>TH</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff><target id="aff1" target-type="aff"><sup>1</sup></target>Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital and Jinan University, Guangzhou 510900, <country>China</country>; <target id="aff2" target-type="aff"><sup>2</sup></target>Department of Urology, Qingyan City People&#x02019;s Hospital, Jinan University, Qingyan, <country>China</country>; <target id="aff3" target-type="aff"><sup>3</sup></target>Department of Urology, Guangzhou First Municipal People&#x02019;s Hospital, Guangzhou 510180, <country>China</country></aff></contrib-group><pub-date pub-type="epub-ppub"><month>4</month><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><volume>5</volume><issue>Suppl 1</issue><elocation-id>AB207</elocation-id><permissions><copyright-statement>2016 Translational Andrology and Urology. All rights reserved.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Translational Andrology and Urology.</copyright-holder></permissions><abstract><sec><title>Objective</title><p>To explore whether combined detrusor and external urethral sphincter botulinum toxin A (BTX-A) injections can decrease leak point pressure (LPP) in patients with incontinence secondary to spinal cord injury (SCI).</p></sec><sec><title>Methods</title><p>A prospective, single-center, single-blind and randomized controlled trial was conducted from June 2013 to August 2015. SCI patients with urinary incontinence secondary to detrusor overactivity and/or low compliance were investigated. At a 1:1 ratio, patients randomly received 200 U BTX-A intradetrusor plus 100 U BTX-A external urethral sphincter (experimental group) or 200 U BTX-A intradetrusor injections (control group). Patients were evaluated at baseline and week 12 after injection. The primary outcomes included LPP and leak point volume (LPV). Secondary outcomes included maximum urethral closure pressure (MUCP), Incontinence-Specific-Quality-of-Life (I-QoL), urinary incontinence episodes, complete dryness, and voiding volume. Adverse events were recorded.</p></sec><sec><title>Results</title><p>Eighty-four patients (44 in experimental group, 40 in control group) had completed the trials. There were no significant differences in baseline characteristics (gender, age, duration of SCI, level of neurological injury, AISA scores) between the two groups. There were significant differences between the experimental and control groups at week 12 for the improvement of LPP (&#x02212;18.54 <italic>vs.</italic> &#x02212;10.14 cmH<sub>2</sub>O, P=0.003), LPV (88.70 <italic>vs</italic>. 55.32 mL, P=0.037), MUCP (&#x02212;29.76 <italic>vs.</italic> &#x02212;7.56 cmH<sub>2</sub>O, P=0.003), I-QoL (37.46 <italic>vs.</italic> 27.64, P=0.004), urinary incontinence(&#x02212;6.68/d <italic>vs.</italic> &#x02212;5.11/d, P=0.014), complete dryness (24 <italic>vs.</italic> 13, P=0.042) and voiding volume (118.94 <italic>vs.</italic> 84.96 mL, P=0.033). We observed eight patients (six in the experimental group, two in the control group) with mild transient hematuria for 2&#x02013;4 days and six patients (two in the experimental group, four in the control group) with bladder discomfort for 6&#x02013;12 hours.</p></sec><sec><title>Conclusions</title><p>Combined detrusor and external urethral sphincter BTX-A injections is more effective than single detrusor BTX-A injections for the improvement of LPP, LPV and the quality of life.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>Detrusor</kwd><kwd>external urethral sphincter</kwd><kwd>botulinum toxin A (BTX-A)</kwd><kwd>incontinence</kwd><kwd>spinal cord injury (SCI)</kwd></kwd-group></article-meta></front></article>